Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1989 1
1991 1
1992 1
1993 1
1997 2
1998 2
1999 2
2000 5
2001 1
2002 5
2003 3
2004 4
2005 5
2006 5
2007 17
2008 24
2009 30
2010 33
2011 46
2012 53
2013 76
2014 82
2015 95
2016 64
2017 56
2018 109
2019 121
2020 141
2021 124
2022 129
2023 126
2024 90
2025 58

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,326 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of throwing exercise with TheraBand in male volleyball players with shoulder internal rotation deficit: a randomized controlled trial.
Moradi M, Hadadnezhad M, Letafatkar A, Khosrokiani Z, Baker JS. Moradi M, et al. BMC Musculoskelet Disord. 2020 Jun 13;21(1):376. doi: 10.1186/s12891-020-03414-y. BMC Musculoskelet Disord. 2020. PMID: 32534582 Free PMC article. Clinical Trial.
A 2 2 analysis of variance with a mixed model design and independent and paired t-tests were used for statistical analysis. CONCLUSIONS: Throwing exercise with a TheraBand improved shoulder muscle activation, IR ROM, rotator cuff muscle strength ratio and GH joint position …
A 2 2 analysis of variance with a mixed model design and independent and paired t-tests were used for statistical analysis. CONCLUSIO …
Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy.
Zhang SH, Peng LL, Chen YF, Xu Y, Moradi V. Zhang SH, et al. Inflamm Regen. 2024 Nov 4;44(1):45. doi: 10.1186/s41232-024-00358-x. Inflamm Regen. 2024. PMID: 39490997 Free PMC article. Review.
Since chimeric antigen receptor T (CAR-T) cells were introduced three decades ago, the treatment using these cells has led to outstanding outcomes, and at the moment, CAR-T cell therapy is a well-established mainstay for treating CD19 + malignancies and multi …
Since chimeric antigen receptor T (CAR-T) cells were introduced three decades ago, the treatment using these cells has led to …
Liposomal delivery system/adjuvant for tuberculosis vaccine.
Moradi M, Vahedi F, Abbassioun A, Ramezanpour Shahi A, Sholeh M, Taheri-Anganeh M, Dargahi Z, Ghanavati R, Khatami SH, Movahedpour A. Moradi M, et al. Immun Inflamm Dis. 2023 Jun;11(6):e867. doi: 10.1002/iid3.867. Immun Inflamm Dis. 2023. PMID: 37382263 Free PMC article. Review.
The paths and challenges of "off-the-shelf" CAR-T cell therapy: An overview of clinical trials.
Moradi V, Omidkhoda A, Ahmadbeigi N. Moradi V, et al. Biomed Pharmacother. 2023 Dec 31;169:115888. doi: 10.1016/j.biopha.2023.115888. Epub 2023 Nov 17. Biomed Pharmacother. 2023. PMID: 37979380 Free article. Review.
The advent of chimeric antigen receptor T cells (CAR-T cells) has made a tremendous revolution in the era of cancer immunotherapy, so that since 2017 eight CAR-T cell products have been granted marketing authorization. ...Nevertheless, for using allogeneic CA …
The advent of chimeric antigen receptor T cells (CAR-T cells) has made a tremendous revolution in the era of cancer immunother …
[Inflammation and osteoarthritis-related pain].
Nees TA, Rosshirt N, Reiner T, Schiltenwolf M, Moradi B. Nees TA, et al. Schmerz. 2019 Feb;33(1):4-12. doi: 10.1007/s00482-018-0346-y. Schmerz. 2019. PMID: 30560495 Review. German.
Although OA has long been considered a non-inflammatory "wear and tear" disease leading to loss of articular cartilage, recent findings provide convincing evidence that inflammatory mechanisms play a pivotal role in the pathophysiology of OA. In OA mononuclear cells (e. g. T …
Although OA has long been considered a non-inflammatory "wear and tear" disease leading to loss of articular cartilage, recent findings prov …
Nanoarchitectonics for Abused-Drug Biosensors.
Moradi R, Khalili NP, Septiani NLW, Liu CH, Doustkhah E, Yamauchi Y, Rotkin SV. Moradi R, et al. Small. 2022 Mar;18(10):e2104847. doi: 10.1002/smll.202104847. Epub 2021 Dec 9. Small. 2022. PMID: 34882957 Review.
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review.
Moradi V, Khodabandehloo E, Alidadi M, Omidkhoda A, Ahmadbeigi N. Moradi V, et al. Front Oncol. 2024 Jun 7;14:1388475. doi: 10.3389/fonc.2024.1388475. eCollection 2024. Front Oncol. 2024. PMID: 38912057 Free PMC article. Review.
Nevertheless, the Expectations of CAR-T cell therapy in solid tumors and non-B cell hematologic malignancies have not been met. ...In recent years the use of gene editing technology in CAR-T cell therapy has opened a new way to unleash the latent potentials of CAR- …
Nevertheless, the Expectations of CAR-T cell therapy in solid tumors and non-B cell hematologic malignancies have not been met. ...In …
Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis.
Rosshirt N, Trauth R, Platzer H, Tripel E, Nees TA, Lorenz HM, Tretter T, Moradi B. Rosshirt N, et al. Arthritis Res Ther. 2021 Jan 22;23(1):37. doi: 10.1186/s13075-020-02410-w. Arthritis Res Ther. 2021. PMID: 33482899 Free PMC article.
The aims of this study were to analyze if synovial inflammation is already present in early OA and to characterize the involved cell populations, by investigating synovial fluid (SF) and synovial membrane (SM) of early OA patients for the presence and polarization status of CD4 …
The aims of this study were to analyze if synovial inflammation is already present in early OA and to characterize the involved cell populat …
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy.
Dehghan F, Metanat Y, Askarizadeh M, Ahmadi E, Moradi V. Dehghan F, et al. Front Cell Dev Biol. 2025 Feb 11;12:1511931. doi: 10.3389/fcell.2024.1511931. eCollection 2024. Front Cell Dev Biol. 2025. PMID: 40007761 Free PMC article. Review.
Currently, CAR-T cell therapy is known as an efficacious treatment for patients with relapsed/refractory hematologic malignancies. ...As a potential alternative, CAR-NK cell therapy can overcome most of the limitations of CAR-T cell therapy and provide an off-the-sh …
Currently, CAR-T cell therapy is known as an efficacious treatment for patients with relapsed/refractory hematologic malignancies. .. …
1,326 results